Xu S, Yuan Z, Jiang C, Chen W, Li Q, Chen T
Adv Sci (Weinh). 2024; 11(16):e2308531.
PMID: 38380551
PMC: 11040361.
DOI: 10.1002/advs.202308531.
Tukek T, Pehlivan S, Medetalibeyoglu A, Serin I, Oyaci Y, Arici H
Pathog Glob Health. 2022; 117(4):392-400.
PMID: 36448222
PMC: 10177741.
DOI: 10.1080/20477724.2022.2151861.
Tuncel F, Serin I, Pehlivan S, Oyaci Y, Pehlivan M
Blood Res. 2022; 57(4):250-255.
PMID: 36289192
PMC: 9812727.
DOI: 10.5045/br.2022.2022097.
Xu S, Jiang C, Lin R, Wang X, Hu X, Chen W
J Exp Clin Cancer Res. 2021; 40(1):373.
PMID: 34823564
PMC: 8613969.
DOI: 10.1186/s13046-021-02186-0.
Xu S, Mo C, Lin J, Yan Y, Liu X, Wu K
Cell Death Discov. 2021; 7(1):226.
PMID: 34462424
PMC: 8405699.
DOI: 10.1038/s41420-021-00614-w.
MicroRNA-106a-3p Induces Apatinib Resistance and Activates Janus-Activated Kinase 2 (JAK2)/Signal Transducer and Activator of Transcription 3 (STAT3) by Targeting the SOCS System in Gastric Cancer.
Guo W, Li W, Yuan L, Mei X, Hu W
Med Sci Monit. 2019; 25:10122-10128.
PMID: 31884511
PMC: 6948289.
DOI: 10.12659/MSM.919610.
Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation.
Xiao Q, Zhou D, Rucki A, Williams J, Zhou J, Mo G
Cancer Res. 2016; 76(18):5395-404.
PMID: 27496707
PMC: 5026619.
DOI: 10.1158/0008-5472.CAN-15-3264.
Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.
Nakamura J, Tanaka T, Kitajima Y, Noshiro H, Miyazaki K
World J Gastroenterol. 2014; 20(34):11991-2006.
PMID: 25232236
PMC: 4161787.
DOI: 10.3748/wjg.v20.i34.11991.
Association between cytokines and methylation of SOCS-1 in serum of patients with ankylosing spondylitis.
Lai N, Chou J, Chen G, Liu S, Lu M, Chan M
Mol Biol Rep. 2014; 41(6):3773-80.
PMID: 24532142
DOI: 10.1007/s11033-014-3242-2.
SOCS-1 promoter methylation and treatment response in chronic hepatitis C patients receiving pegylated-interferon/ribavirin.
Tseng K, Chou J, Huang H, Tseng C, Wu S, Chan M
J Clin Immunol. 2013; 33(6):1110-6.
PMID: 23702664
DOI: 10.1007/s10875-013-9903-4.
Somatic mutations, allele loss, and DNA methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) gene reveals association with early age of diagnosis in colorectal cancer patients.
Shull A, Clendenning M, Ghoshal-Gupta S, Farrell C, Vangapandu H, Dudas L
PLoS One. 2013; 8(3):e58731.
PMID: 23505554
PMC: 3591376.
DOI: 10.1371/journal.pone.0058731.
Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine.
Chen P, Tsai M, Yip S, Jou Y, Ng C, Chen Y
BMC Med Genomics. 2011; 4:45.
PMID: 21599969
PMC: 3127971.
DOI: 10.1186/1755-8794-4-45.
Specificity of methylation assays in cancer research: a guideline for designing primers and probes.
Barekati Z, Radpour R, Kohler C, Zhong X
Obstet Gynecol Int. 2010; 2010.
PMID: 20798774
PMC: 2926695.
DOI: 10.1155/2010/870865.
Acid-induced p16 hypermethylation contributes to development of esophageal adenocarcinoma via activation of NADPH oxidase NOX5-S.
Hong J, Resnick M, Behar J, Wang L, Wands J, DeLellis R
Am J Physiol Gastrointest Liver Physiol. 2010; 299(3):G697-706.
PMID: 20576920
PMC: 2950676.
DOI: 10.1152/ajpgi.00186.2010.
Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer.
Chou J, Su H, Chen L, Liao Y, Hartman-Frey C, Lai Y
Lab Invest. 2010; 90(3):414-25.
PMID: 20065949
PMC: 2829100.
DOI: 10.1038/labinvest.2009.138.
MethySYBR, a novel quantitative PCR assay for the dual analysis of DNA methylation and CpG methylation density.
Lo P, Watanabe H, Cheng P, Teo W, Liang X, Argani P
J Mol Diagn. 2009; 11(5):400-14.
PMID: 19710398
PMC: 2729837.
DOI: 10.2353/jmoldx.2009.080126.
Quantification of regional DNA methylation by liquid chromatography/tandem mass spectrometry.
Liu Z, Wu J, Xie Z, Liu S, Fan-Havard P, Huang T
Anal Biochem. 2009; 391(2):106-13.
PMID: 19442645
PMC: 3939067.
DOI: 10.1016/j.ab.2009.05.012.
Aberrant expression and demethylation of gamma-synuclein in colorectal cancer, correlated with progression of the disease.
Ye Q, Zheng M, Cai Q, Feng B, Chen X, Yu B
Cancer Sci. 2008; 99(10):1924-32.
PMID: 19016751
PMC: 11158015.
DOI: 10.1111/j.1349-7006.2008.00947.x.
Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer.
Cheng Y, Jin H, Liu X, Siu J, Wong Y, Ng E
Br J Cancer. 2008; 99(12):2083-7.
PMID: 18985039
PMC: 2607230.
DOI: 10.1038/sj.bjc.6604760.
SOCS-3 inhibits E2F/DP-1 transcriptional activity and cell cycle progression via interaction with DP-1.
Masuhiro Y, Kayama K, Fukushima A, Baba K, Soutsu M, Kamiya Y
J Biol Chem. 2008; 283(46):31575-83.
PMID: 18687693
PMC: 2581570.
DOI: 10.1074/jbc.M800328200.